TORIGEN PHARMACEUTICALS
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals. They strive to bring novel approaches to the market to tackle companion animal cancers, building on years of existing scientific research and pushing the boundaries of innovation. The company was founded in 2013 by Ashley Kalinauskas and Mark Suckow and is based in Farmington, Connecticut, United States.
TORIGEN PHARMACEUTICALS
Industry:
Biotechnology Health Care Veterinary
Founded:
2013-01-01
Address:
Farmington, Connecticut, United States
Country:
United States
Website Url:
http://www.torigen.com
Total Employee:
11+
Status:
Active
Contact:
860-519-9956
Total Funding:
7.71 M USD
Technology used in webpage:
Viewport Meta Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Domain Not Resolving Global Site Tag Organization Schema AJAX Libraries API
Similar Organizations
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Current Advisors List
Board_member
2019-01-01
Current Employees Featured
John Kallassy CFO @ Torigen Pharmaceuticals
CFO
2018-01-01
Ashley Kalinauskas Founder & CEO @ Torigen Pharmaceuticals
Founder & CEO
2013-05-01
Mark Suckow Co-Founder & CTO @ Torigen Pharmaceuticals
Co-Founder & CTO
Founder
Investors List
UConn Innovation Fund - University of Connecticut
UConn Innovation Fund - University of Connecticut investment in Series A - Torigen Pharmaceuticals
Emerald Development Managers
Emerald Development Managers investment in Series A - Torigen Pharmaceuticals
SoGal Ventures
SoGal Ventures investment in Series A - Torigen Pharmaceuticals
Connecticut Innovations
Connecticut Innovations investment in Series A - Torigen Pharmaceuticals
The Fund
The Fund investment in Seed Round - Torigen Pharmaceuticals
MassChallenge
MassChallenge investment in Non Equity Assistance - Torigen Pharmaceuticals
Official Site Inspections
http://www.torigen.com Semrush global rank: 5.08 M Semrush visits lastest month: 1.62 K
- Host name: ec2-35-158-87-123.eu-central-1.compute.amazonaws.com
- IP address: 35.158.87.123
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
Torigen.com lookup results from whois.tucows.com server:
- Domain created: 2nd-Oct-2012
- Domain updated: 17th-Sep-2024
- Domain expires: 2nd-Oct-2025 0 Years, 150 Days left
- Website age: 12 Years, 214 Days
- Registrar Domain ID: 1749429733_DOMAIN_COM-VRSN
- Registrar Url: http://www.tucows.com
- Registrar WHOIS Server: whois.tucows.com
- Registrar Abuse Contact Email: domainabuse@tucows.com
- Registrar Abuse Contact Phone: +1.4165350123
- Name server:
- DNS1.P06.NSONE.NET
- DNS2.P06.NSONE.NET
- DNS3.P06.NSONE.NET
- DNS4.P06.NSONE.NET
- NS01.SQUARESPACEDNS.COM
- NS02.SQUARESPACEDNS.COM
- NS03.SQUARESPACEDNS.COM
- NS04.SQUARESPACEDNS.COM
More informations about "Torigen Pharmaceuticals"
Torigen Pharmaceuticals | Veterinary Cancer Treatment
At Torigen, Dr. Lucroy is responsible for new product innovation, clinical studies, and developing an incredible team to bring Torigen to the next level. Dr. Chelsea Greenberg, MS, DVM, DACVIM(O) Dr. Greenberg serves as our Vice …See details»
Torigen Pharmaceuticals - Crunchbase Company …
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals. They strive to bring novel approaches to the market to tackle companion animal cancers, building on years of existing scientific research and pushing the …See details»
Torigen Pharmaceuticals - Overview, News & Similar companies
Apr 24, 2023 View Torigen Pharmaceuticals (www.torigen.com) location in Connecticut, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Torigen, Inc. Overview | SignalHire Company Profile
Torigen is committed to helping improve the lives of pets by harnessing the power of their immune systems to change the way cancer is treated with an individualized vaccine. ... Organization …See details»
Torigen - Company Profile - Tracxn
Dec 6, 2024 Torigen. has raised a total funding of $20.8M over 6 rounds. Its first funding round was on 2017. What are the most recent funding rounds of Torigen? Its latest funding round …See details»
Torigen Pharmaceuticals - Craft
Torigen Pharmaceuticals is a company focused on veterinary cancer care. Its product, VetiVax, is a cancer immunotherapy that uses the patient's own tumor cells to create a personalized …See details»
TORIGEN PHARMACEUTICALS, INC. - Dun & Bradstreet
Torigen pharmaceuticals, inc. d&b business directory home / business directory / wholesale trade / merchant wholesalers, nondurable goods / drugs and druggists' sundries merchant …See details»
Torigen Pharmaceuticals - The Org
Torigen Pharmaceuticals is focused on veterinary cancer care. Their product, VetiVax, is a revolutionary cancer immunotherapy that uses the patient's own tumor cells to create a …See details»
TORIGEN Company Profile | Vernon, CT - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TORIGEN of Vernon, CT. Get the latest business insights from Dun & Bradstreet.See details»
Torigen Pharmaceuticals - PitchBook
Torigen Pharmaceuticals General Information Description. Operator of an immunotherapy cancer treatment company intended to detect and treat cancer among animals. The company's experimental autologous cancer vaccine …See details»
Torigen Pharmaceuticals, Inc. - BioCT
Torigen Pharmaceuticals, Inc. is focused on providing veterinary cancer care solutions for companion animals. Our novel, personalized immunotherapy uses the animals’ existing tumor …See details»
Torigen, Inc. Company Profile: , Investments, Contact Information, …
Torigen is committed to helping improve the lives of pets by harnessing the power of their immune systems to change the way cancer is treated with an individualized vaccine. Cancer affects …See details»
Torigen Pharmaceuticals Opens New Headquarters and Promotes …
Apr 25, 2023 Connecticut-based animal biologics company builds momentum in Q2 2023 with state-of-the-art production facility and team expansion. FARMINGTON, Conn., April 25, 2023 …See details»
Torigen Pharmaceuticals
Torigen demonstrated that the overall median survival time for dogs treated with our Autologous Prescription Product was survival similar to dogs treated with maximum-tolerated dose …See details»
Torigen - CoBee Company Profile & Funding Rounds
Torigen is a Connecticut-based pharmaceutical company that researches and develops cancer immunotherapies for the veterinary market. Contact Phone: +18605199956 Contact Email: …See details»
Torigen Pharmaceuticals Company Profile: Overview and Full News …
Torigen Pharmaceuticals, a company developing personalized cancer immunotherapies for the veterinary market, announced today the completion of a $3.1 million Series A financing round …See details»
Torigen’s Competitors, Revenue, Number of Employees, Funding
Torigen’s Profile, Revenue and Employees. Torigen is a Connecticut-based pharmaceutical company that researches and develops cancer immunotherapies for the veterinary market. …See details»
Torigen - Overview, News & Similar companies | ZoomInfo.com
Torigen is a company that operates in the Information Technology and Services industry. It employs 11-20 people and has $1M-$5M of revenue. The company is headquartered in …See details»
How Torigen is changing the fight against small animal cancer
Dec 3, 2019 The founders of Torigen have developed a revolutionary immunotherapy treatment that’s effectively treating cancer in dogs and cats. Our dogs and cats are integral members of …See details»